NYC restaurants starved by pandemic threaten lawsuit to bring back indoor dining
A New York City Hospitality Alliance survey found that 83 percent of 471 bars and restaurants did not pay full rent in July and 37% paid no rent at all.
Coronavirus pandemic pushes expansion of 'hospital at home' treatment
Across the U.S., “hospital at home” programs are taking off amid the pandemic, thanks to communications technology, portable medical equipment and teams of doctors, nurses, X-ray techs and paramedics.
USDA ignored concerns about coronavirus on meat products and packaging, doctor group alleges in lawsuit
A pro-vegan physicians group is suing the U.S. Department of Agriculture for coronavirus warning labels on meat.
General Mills recalls mislabeled Progresso soup cans over allergen concerns
The company's recall covers less than 3,000 cans of its 14-ounce cans of Progresso Organic Chicken Noodle Soup are said to contain allergens including soy and dairy, which are not labeled on the can.
J&J strikes $6.5B deal for autoimmune disease specialist Momenta
The deal gives J&J's Janssen unit access to Momenta's experimental therapy, nipocalimab, being tested for myasthenia gravis, a neuromuscular disease that causes weakness in muscles, and other diseases where the immune system attacks the body.
Pope: rich can't get priority for vaccine, poor need help
Pope Francis on Wednesday it would be "sad" to prioritize giving a COVID-19 vaccines "to the richest" rather than the poor.
Australia announces free coronavirus vaccine deal
Australia has announced a deal to manufacture a potential coronavirus vaccine being developed by British-Swedish pharmaceutical company AstraZenec.
Bill Gates: If 30-60% of Americans take coronavirus vaccine, 'exponential spread' will stop
Bill Gates said Tuesday that if just 30-60 percent of the U.S. population get a coronavirus vaccine, that will be enough to slow the spread.
FDA warns of false coronavirus test results from Thermo Fisher kit
The Food and Drug Administration on Monday warned health care providers of false-positive coronavirus test results using the Thermo Fisher Scientific TaqPath COVID-19 Combo Kit.
Delta partners with CVS to accelerate COVID-19 testing
Delta Airlines announced Tuesday a partnership with CVS Health to speed up employee COVID-19 testing that the company said would “build confidence about traveling” for its customers.
LA mayor embraces new COVID-19 testing strategy: simplicity and speed
Proponents say that rapid, at-home COVID-19 testing would allow for real-time detection of new clusters of cases, including asymptomatic individuals -- before they can spread.
Trump taps McKesson as coronavirus vaccine distributor
Three U.S. companies are currently in Phase 3 clinical trials of vaccines and are on pace to develop one before the end of the year. The country expects 500 million doses to be available before Dec. 31, Trump said during a news conference.
3 Medicare mistakes to avoid during the coronavirus pandemic
Here are three Medicare mistakes to avoid at all costs during the ongoing crisis.
Mitt Romney raises alarm about state of Social Security and Medicare trust funds
Romney said that "we need to take action now" or risk significant cuts to Medicare and Social Security benefits.
Reopening school during coronavirus means sneeze guards on desks and digital thermometers at the door
As tens of millions of students across the country return to schools this month for the first time since March, teachers and principals are scrambling to jury-rig their classrooms, hallways and schedules to keep students physically distanced inside of buildings created to bring them together.
New COVID-19 cases top 50,000 in US for second straight day
New coronavirus cases in the U.S. topped 50,000 for the second day in a row, as countries around the world struggled to curb the virus’s spread.
Toxic hand sanitizer recall due to 'deliberate decision' by manufacturers to cut costs
All of the cleaners were recalled by the manufacturer or distributor after testing positive for methanol.
US government strikes deal with Moderna for 100M coronavirus vaccine doses
The deal is valued at up to $1.5 billion.
Kodak addresses controversial halted $765M loan amid SEC probe, says 'more work is necessary'
Kodak executives face allegations of wrongdoing related to a government loan to produce pharmaceutical supplies.
Coronavirus ‘spit test’ used by NBA nearing FDA approval
The FDA is on the verge of approving a saliva-based coronavirus test created by researchers at the Yale School of Public Health.



















